Category: Endocrinology

Endocrinologists

Endocrinology

One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 17, Issue 10, 2023 Oct, Article 102858 | Li, Yulong; Li, Jiawen; Guan, Changdong;…AbstractBackgroundPatients with diabetes and coronary artery disease have a higher risk of bleeding and thrombotic events. However, data on the safety and efficacy of bivalirudin in these patients undergoing elective percutaneous coronary interven… Source

Endocrinology

Associations of artificially sweetened beverages, sugar-sweetened beverages, and pure fruit/vegetable juice with visceral adipose tissue mass

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 17, Issue 10, 2023 Oct, Article 102871 | Yu, Bowei; Sun, Ying; Wang, Yuying;…AbstractObjectiveTo test the associations of sugar-sweetened beverage, artificially sweetened beverage, and pure fruit/vegetable juice consumption with visceral adipose tissue (VAT) mass at baseline and follow-up and to determine whether BMI and g… Source

Endocrinology

Adherence to healthy lifestyle was associated with an attenuation of the risk of chronic kidney disease from metabolic dysfunction–associated fatty liver disease: Results from two prospective cohorts

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 17, Issue 10, 2023 Oct, Article 102873 | Zhang, Yixiao; Zhang, Tingjing; Liu, Yashu;…AbstractAimsNon-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction–associated fatty liver disease (MAFLD) are important risk factors of chronic kidney disease (CKD). Whether adherence to a healthy lifestyle can modify these effects re… Source

Endocrinology

Does fear drive health app adoption? The role of threat perception in diabetes app usage

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 17, Issue 10, 2023 Oct, Article 102857 | Gopalakrishnan, T.R.; Jacob, Rachel; Periyandavar, I.AbstractBackground and aimThis study explores the interplay between fear or threat perception and adoption of health apps among individuals with diabetes. It draws on the concept of “fear” as an emotional response stemming from perceived threat, r… Source

Endocrinology

Optimal use of once weekly icodec insulin in type-2 diabetes: An updated meta-analysis of phase-2 and phase-3 randomized controlled trials

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 17, Issue 10, 2023 Oct, Article 102877 | Dutta, Deep; Nagendra, Lakshmi; Bhat, Sowrabha;…AbstractBackgroundPreviously published meta-analysis have analysed data from 3 small phase-2 randomized controlled trials (RCTs). Since then, 5 big phase-3 RCTs have been published on use of icodec in type-2 diabetes (T2D). This updated systematic… Source